Showing 8,961 - 8,980 results of 66,855 for search '(((( 5 mg decrease ) OR ( e point decrease ))) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.13s Refine Results
  1. 8961
  2. 8962
  3. 8963
  4. 8964

    HIV‑1 Infection Reduces NAD Capping of Host Cell snRNA and snoRNA by Barbora Benoni (18562553)

    Published 2024
    “…Nicotinamide adenine dinucleotide (NAD) is a critical component of the cellular metabolism and also serves as an alternative 5′ cap on various RNAs. …”
  5. 8965

    Table_5_Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population.xlsx by Robert W. Read (6248582)

    Published 2021
    “…The study identified 549 significant single-variant associations (p < 8.75 × 10<sup>–9</sup>), many in chromosome 11’s triglyceride hotspot: ZPR1, BUD13, APOC3, APOA5. A well-known protective loss-of-function variant in APOC3 (R19X) was associated with a 51% decrease in triglyceride levels in the cohort. …”
  6. 8966

    Table 5_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…High-frequency mutations were found in PTEN, ARID1A, and UBR4. Genes like COX5B and MS4A1 emerged as potential predictors of clinical outcomes and therapeutic response. …”
  7. 8967
  8. 8968

    Battery parameters. by Peijian Jin (22265437)

    Published 2025
    “…We observed a pattern in which the time intervals between the waveforms decreased rapidly at first and then stabilized. …”
  9. 8969

    Cytokine levels in the serum of mice before and 1.5 hours after transfusion with human blood. by Sophia A. Blessinger (9193266)

    Published 2020
    “…<p>(<b>A</b>) Cytokines increased by transfusion: Eotaxin, MIP-1β, and IP-10. …”
  10. 8970

    The aging parameters of each group of batteries. by Peijian Jin (22265437)

    Published 2025
    “…We observed a pattern in which the time intervals between the waveforms decreased rapidly at first and then stabilized. …”
  11. 8971

    Minimal data set. by Peijian Jin (22265437)

    Published 2025
    “…We observed a pattern in which the time intervals between the waveforms decreased rapidly at first and then stabilized. …”
  12. 8972

    Experimental lithium-ion batteries. by Peijian Jin (22265437)

    Published 2025
    “…We observed a pattern in which the time intervals between the waveforms decreased rapidly at first and then stabilized. …”
  13. 8973

    Schematic diagram of two time intervals. by Peijian Jin (22265437)

    Published 2025
    “…We observed a pattern in which the time intervals between the waveforms decreased rapidly at first and then stabilized. …”
  14. 8974
  15. 8975

    Table_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”
  16. 8976

    Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”
  17. 8977

    Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”
  18. 8978

    Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”
  19. 8979

    Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”
  20. 8980

    Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”